The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DNA methylation profile to predict clinical outcome of anti-EGFR treatment in metastatic colorectal cancer.
 
Kota Ouchi
No Relationships to Disclose
 
SHIN Takahashi
Speakers' Bureau - Chugai Pharma; Taiho Pharmaceutical
 
Yasuhide Yamada
Speakers' Bureau - Chugai Pharma; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Merck Serono (Inst); Novartis (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Shingo Tsuji
No Relationships to Disclose
 
Kenji Tatsuno
No Relationships to Disclose
 
Hidekazu Takahashi
No Relationships to Disclose
 
Naoki Takahashi
No Relationships to Disclose
 
Masanobu Takahashi
Speakers' Bureau - Yakult Pharmaceutical
 
Hideki Shimodaira
Speakers' Bureau - Bayer; Chugai Pharma; Merck Serono; Nichi-iko; Takeda; Yakult Pharmaceutical
 
Hiroyuki Aburatani
Research Funding - Forerunner Pharma Research (Inst); Takeda (Inst)
 
Chikashi Ishioka
Speakers' Bureau - Asahi Kasei; Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Merck Serono (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)